OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
10/10/2025
Back to search
Official data from USPTO
NEC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079394301Class
5, 9, 35, 42, 44
Filing
79394301
Registration
7665783
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
10/11/2025
Trademark type
Combined
Nice classes
5, 9, 35, 42, 44
Filing date
11/08/2023
Registration date
01/28/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/28/2025
Last transaction
10/11/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
JP
Examiner
GUARNIERI,GRACE K
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the letters "NEC" in stylized block text.
Holders and representatives
Holders
Nippon Denki Kabushiki Kaisha (NEC Corporation)
Representatives
Richard Y. Kim Snell & Wilmer L.L.P.
Technical classification
Nice Classes
Class 5Class 9Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines; vaccines preparations; vaccine preparations for the prevention and treatment of cancerinfection and auto immune disease; pharmaceuticals and pharmaceutical preparations for human use for the prevention and treatment of cancerinfection and auto immune disease; companion diagnostic agents for medical use; pharmaceutical preparations for the treatment and prevention of cancerinfection and auto immune disease namely cellular therapeutics; pharmaceutical preparations for the treatment of cell related viral diseases; reagent paper for medical purposes; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposesdrinks for babies; food for babies; dietary supplements for animals
Class 9
Downloadable and recorded computer software for use in analyzing and identifying genome information; Downloadable and recorded computer software for medical process management of individual personalized treatment; Downloadable and recorded computer software for patient stratification; Downloadable and recorded operating system computer software for use with companion diagnostic medical devices; Downloadable and recorded computer software platforms for use in medical data management; Downloadable and recorded computer operating programs; Downloadable and recorded computer operating system software; computers and computer hardware; computer network servers; computer peripheral apparatus; Downloadable and recorded computer software and downloadable application software for collecting and storage of patient data and medical information; Data processing equipment in the nature of data processing systems for collecting and storage of patient data and medical information
Class 35
Collection of information into computer databases in the field of genetic and genomic information and life science; Collection of genome information into computer databases for medical purposes; collection of information into computer databases in the field of medical information
Class 42
Research and development of vaccines and medicines; scientific research in the nature of conducting clinical trials for others; research and development of medicines in the nature of companion diagnostic agent; testinginspection or research of pharmaceuticalscosmetics or foodstuffs; scientific research in the field of genetics; medical research; design and development of computer hardware and software for use in companion diagnostic; designing of machinesapparatusinstruments and their parts or systems composed of such machinesapparatus and instruments; technology advisory and consultancy services relating to the design and development of computer hardware; computer programming; medical and scientific research in the field of gene analysis; Scientific and technological servicesgenome researchtestinganalysisevaluation of genome samples for scientific research purposes and providing information thereof; Scientific and technological servicesinvestigation and analysis of genome samples for scientific research purposes; providing on-line non downloadable software for use in analyzing and identifying genome information; providing on-line non downloadable software for medical process management of individual personalized treatment; providing on-line non downloadable software for patient stratification; providing on-line non downloadable operating system software for use with companion diagnostic medical devices; platform as a service (PaaS) featuring computer software platforms for use in medical data management; design and development of computer software for medical data analysis and management; rental of computers; providing temporary use of on-line non- downloadable cloud computing software and computer programs on data networks for medical data management; software as a service (SaaS) featuring software for medical data management; research and development in the field of cellular therapeutics; structural and functional analysis of genomes; Providing information about medical researchgenome information analysis; Scientific and technological servicesproviding scientific analysis in the field of genomic data; providing on-line non downloadable software for use in collectinganalyzingevaluatinginterpreting and predicting genetic and genomic information; providing science information in the fields of genetic and genomic information and life science; Biological research in the nature of analysis of biological samples
Class 44
Providing medical information related to the preservation of genome information for medical purposes; Providing medical information in the nature of collected genome information; providing medical information in the field of cellular therapeutics; medical diagnostic testing and monitoring services in the field of cellular therapeuticscell therapy; medical assistance services in the nature of information about genetic testing and medical information provided to remote medical professionals via the Internet and global computer networks through the use of genome sequence informationmedical imagesdiagnostic test resultsdata storage and retrieval systems; medical services relating to the collectionprocessing and preservation of biological samples; collection and preservation of biological sampleshuman cells; medical laboratory services for the analysis of biological samples; medical analysis services for diagnostic and treatment provided by medical laboratories relating to celltissuegene expressiongene sequencegenome annotationtranscriptome characteristic analysisgenome mapping; provision of medical information; physical examination services; providing an internet website for medical professionals and medical patients featuring medical information and medical data which users processexchange and access in real time
Publications
History of USPTO decisions and trademark events.
30 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/24/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/24/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/05/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/16/2025
FIMP
FINAL DISPOSITION PROCESSED
08/16/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/29/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/28/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/28/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/10/2024
PUBO
PUBLISHED FOR OPPOSITION
12/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/14/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
11/08/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/08/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
11/08/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/16/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/16/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/16/2024
RFNT
REFUSAL PROCESSED BY IB
08/11/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/23/2024
RFRR
REFUSAL PROCESSED BY MPU
07/23/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/27/2024
CNRT
NON-FINAL ACTION WRITTEN
06/26/2024
DOCK
ASSIGNED TO EXAMINER
06/17/2024
MAFR
APPLICATION FILING RECEIPT MAILED
05/10/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/10/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
05/02/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/25/2024
Continuous trademark protection
Get notified about every new filing that threatens NEC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.